Literature DB >> 2555763

Role of mononuclear phagocytes in elimination of Plasmodium chabaudi AS infection.

M M Stevenson1, E Ghadirian, N C Phillips, D Rae, J E Podoba.   

Abstract

The role of mononuclear phagocytes in acquired immunity resulting in the intraerythrocytic destruction and elimination of malarial parasites was investigated in the murine model of infection with Plasmodium chabaudi AS. Mice were treated 1 day before or 6 days after infection with agents which either result in augmentation or activation of the non-specific, microbicidal effector function of mononuclear phagocytes or in depletion of cells of this lineage. To examine the effect of agents which activate mononuclear phagocytes. A/J mice, which are susceptible to P. chabaudi AS and exhibit fulminant parasitaemia and death within 10 days of intraperitoneal infection with 10(6) P-RBC, were treated intravenously with muramyl dipeptide (MDP) or liposome-encapsulated MDP-glycerol dipalmitate (MDP-GDP). Treatment administered 1 day before infection was ineffective. Treatment on day 6 post-infection with liposome-encapsulated MDP-GDP (1 microgram) resulted in a significant decrease in parasitaemia on day 8 and survival, while treatment with free MDP (100 micrograms) resulted only in a significant decrease in parasitaemia. To examine the effect of depletion of mononuclear phagocytes, C57BL/6 mice, which are resistant to P. chabaudi AS infection and eliminate the parasite by 4 weeks, were treated intravenously with 3 mg silica. Silica administered 1 day before or 6 days post-infection abrogated resistance resulting in a delay in elimination of the parasite and host mortality. Treatment on day 6 was more effective, with death by day 13 post-infection of 70% of the normally resistant C57BL/6 mice which exhibited fulminant parasitaemia levels. These results thus provide in-vivo evidence that mononuclear phagocytes play a critical role in the elimination of infection with the murine malaria species P. chabaudi AS. Furthermore, these results suggest that the time of administration of agents which alter mononuclear phagocyte function may be important in determining their effect on host antimalarial defences.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555763     DOI: 10.1111/j.1365-3024.1989.tb00687.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  20 in total

1.  Gamma interferon production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither NO production nor NK cell activation is critical.

Authors:  T Yoneto; T Yoshimoto; C R Wang; Y Takahama; M Tsuji; S Waki; H Nariuchi
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Macrophages are critical for cross-protective immunity conferred by Babesia microti against Babesia rodhaini infection in mice.

Authors:  Yan Li; Mohamad Alaa Terkawi; Yoshifumi Nishikawa; Gabriel Oluga Aboge; Yuzi Luo; Hideo Ooka; Youn-Kyoung Goo; Longzheng Yu; Shinuo Cao; Yongfeng Sun; Junya Yamagishi; Tatsunori Masatani; Naoaki Yokoyama; Ikuo Igarashi; Xuenan Xuan
Journal:  Infect Immun       Date:  2011-11-07       Impact factor: 3.441

3.  Depletion of Phagocytic Cells during Nonlethal Plasmodium yoelii Infection Causes Severe Malaria Characterized by Acute Renal Failure in Mice.

Authors:  Mohamad Alaa Terkawi; Maki Nishimura; Hidefumi Furuoka; Yoshifumi Nishikawa
Journal:  Infect Immun       Date:  2016-01-11       Impact factor: 3.441

4.  Macrophages are the determinant of resistance to and outcome of nonlethal Babesia microti infection in mice.

Authors:  Mohamad Alaa Terkawi; Shinuo Cao; Maria S Herbas; Maki Nishimura; Yan Li; Paul Franck Adjou Moumouni; Asadullah Hamid Pyarokhil; Daisuke Kondoh; Nobuo Kitamura; Yoshifumi Nishikawa; Kentaro Kato; Naoaki Yokoyama; Jinlin Zhou; Hiroshi Suzuki; Ikuo Igarashi; Xuenan Xuan
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

5.  Role of endogenous gamma interferon in host response to infection with blood-stage Plasmodium chabaudi AS.

Authors:  M M Stevenson; M F Tam; M Belosevic; P H van der Meide; J E Podoba
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

6.  Early IL-12 p70, but not p40, production by splenic macrophages correlates with host resistance to blood-stage Plasmodium chabaudi AS malaria.

Authors:  H Sam; M M Stevenson
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

7.  Macrophage-mediated but gamma interferon-independent innate immune responses control the primary wave of Plasmodium yoelii parasitemia.

Authors:  Kevin N Couper; Daniel G Blount; Julius C R Hafalla; Nico van Rooijen; J Brian de Souza; Eleanor M Riley
Journal:  Infect Immun       Date:  2007-10-08       Impact factor: 3.441

8.  Rosiglitazone modulates the innate immune response to Plasmodium falciparum infection and improves outcome in experimental cerebral malaria.

Authors:  Lena Serghides; Samir N Patel; Kodjo Ayi; Ziyue Lu; D Channe Gowda; W Conrad Liles; Kevin C Kain
Journal:  J Infect Dis       Date:  2009-05-15       Impact factor: 5.226

9.  Altered immune responses in mice with concomitant Schistosoma mansoni and Plasmodium chabaudi infections.

Authors:  H Helmby; M Kullberg; M Troye-Blomberg
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

10.  CD4+ and CD8+ T lymphocytes both contribute to acquired immunity to blood-stage Plasmodium chabaudi AS.

Authors:  J E Podoba; M M Stevenson
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.